C反应蛋白与动脉粥样硬化性心脑血管病

[1] From syndromes to specific disease mechanisms.The search for the causes of myocardial infarction. Maseri A. Italian Heart Journal . 2000

[2] C-Reactive protein concentrations and angiographic characteristics of coronary lesions. Katritsis D,Korovesis S,Giazitzoglou E,et al. Clinical Chemistry . 2001

[3] Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Rost NS,Wolf PA,Kase CS,et al. Stroke . 2001

[4] Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Chew DP,Bhatt DL,Robbins MA,et al. Circulation . 2001

[5] Risk factors and atherosclerotic lesions.A review of autopsy studies. Solberg LA,Strong JP. Arteriosclerosis . 1983

[6] Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Stefanadis C,Diamantopoulos L,Vlachopoulos C,et al. Circulation . 1999

[7] Topology and structure of the C1q-binding site on C-reactive protein. Agrawal A,Shrive AK,Greenhough TJ,et al. J Immunol . 2001

[8] Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Lindahl B,Toss H,Siegbahn A,et al. The New England Journal of Medicine . 2000

[9] Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. Buffon A,Liuzzo G,Biasucci LM,et al. Journal of the American College of Cardiology . 1999

[10] Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Ridker PM,Rifai N,Lowenthal SP. Circulation . 2001

[1] From syndromes to specific disease mechanisms.The search for the causes of myocardial infarction. Maseri A. Italian Heart Journal . 2000

[2] C-Reactive protein concentrations and angiographic characteristics of coronary lesions. Katritsis D,Korovesis S,Giazitzoglou E,et al. Clinical Chemistry . 2001

[3] Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Rost NS,Wolf PA,Kase CS,et al. Stroke . 2001

[4] Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Chew DP,Bhatt DL,Robbins MA,et al. Circulation . 2001

[5] Risk factors and atherosclerotic lesions.A review of autopsy studies. Solberg LA,Strong JP. Arteriosclerosis . 1983

[6] Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Stefanadis C,Diamantopoulos L,Vlachopoulos C,et al. Circulation . 1999

[7] Topology and structure of the C1q-binding site on C-reactive protein. Agrawal A,Shrive AK,Greenhough TJ,et al. J Immunol . 2001

[8] Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Lindahl B,Toss H,Siegbahn A,et al. The New England Journal of Medicine . 2000

[9] Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. Buffon A,Liuzzo G,Biasucci LM,et al. Journal of the American College of Cardiology . 1999

[10] Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Ridker PM,Rifai N,Lowenthal SP. Circulation . 2001